4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-22-127082
Options or other derivatives
- Chief Technology Officer acquired 33,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Medarova Zdravka Chief Technology Officer | 2022-02-01 | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | D | ||
Loading xslF345X03/tm2232745-4_4seq1.xml…